Gut microbiome: decision-makers in the microenvironment of colorectal cancer
Jingrun Han,Biao Zhang,Yongnian Zhang,Tianyi Yin,Yuying Cui,Jinming Liu,Yanfei Yang,Huiyi Song,Dong Shang
DOI: https://doi.org/10.3389/fcimb.2023.1299977
IF: 6.073
2023-12-12
Frontiers in Cellular and Infection Microbiology
Abstract:Colorectal cancer (CRC) is a common malignancy of the gastrointestinal tract, accounting for the second most common cause of gastrointestinal tumors. As one of the intestinal barriers, gut bacteria form biofilm, participate in intestinal work, and form the living environment of intestinal cells. Metagenomic next-generation sequencing (mNGS) of the gut bacteria in a large number of CRC patients has been established, enabling specific microbial signatures to be associated with colorectal adenomato-carcinoma. Gut bacteria are involved in both benign precursor lesions (polyps), in situ growth and metastasis of CRC. Therefore, the term tumorigenic bacteria was proposed in 2018, such as Escherichia coli , Fusobacterium nucleatum , enterotoxigenic Bacteroides fragilis , etc. Meanwhile, bacteria toxins (such as cytolethal distending toxin (CDT), Colibactin (Clb), B. fragilis toxin) affect the tumor microenvironment and promote cancer occurrence and tumor immune escape. It is important to note that there are differences in the bacteria of different types of CRC. In this paper, the role of tumorigenic bacteria in the polyp-cancer transformation and the effects of their secreted toxins on the tumor microenvironment will be discussed, thereby further exploring new ideas for the prevention and treatment of CRC.
immunology,microbiology